The Advisory Team at Scandion Oncology provides critical insights and guidance on clinical and scientific matters, leveraging their expertise to advance the development of treatments for drug-resistant cancers. Their collective knowledge helps to shape research strategies, clinical trial designs, and regulatory approaches to improve therapeutic outcomes.